NeueHealth, Inc.
NEUE
$6.49
-$0.11-1.67%
09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
---|---|---|---|---|---|
Revenue | 60.38M | 49.77M | 49.56M | 352.04M | 37.85M |
Total Other Revenue | 209.02M | 248.22M | 250.99M | 199.38M | 155.51M |
Total Revenue | 269.40M | 297.98M | 300.55M | 551.43M | 193.36M |
Cost of Revenue | 226.44M | 245.16M | 260.12M | 519.29M | 152.15M |
Gross Profit | 42.96M | 52.82M | 40.43M | 32.13M | 41.21M |
SG&A Expenses | 94.95M | 70.28M | 79.52M | 185.73M | 85.58M |
Depreciation & Amortization | 4.12M | 4.67M | 5.48M | 10.40M | 8.95M |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 325.51M | 320.11M | 345.12M | 715.42M | 246.67M |
Operating Income | -56.11M | -22.13M | -44.57M | -164.00M | -53.31M |
Income Before Tax | -482.69M | -32.58M | -52.66M | -192.46M | -100.83M |
Income Tax Expenses | -3.39M | -892.00K | 1.26M | -4.23M | 3.40M |
Earnings from Continuing Operations | -479.31M | -31.69M | -53.92M | -188.23M | -104.23M |
Earnings from Discontinued Operations | -67.84M | -56.94M | -115.54M | -480.33M | -165.90M |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -86.75M | -24.21M | -5.55M | -11.01M | -46.71M |
Net Income | -633.90M | -112.83M | -175.01M | -679.57M | -316.84M |
EBIT | -56.11M | -22.13M | -44.57M | -164.00M | -53.31M |
EBITDA | -51.99M | -21.87M | -34.68M | -153.60M | -44.36M |
EPS Basic | -81.03 | -15.70 | -23.68 | -88.00 | -41.48 |
Normalized Basic EPS | -16.83 | -5.50 | -4.85 | -14.96 | -10.56 |
EPS Diluted | -81.03 | -15.70 | -23.68 | -88.00 | -41.48 |
Normalized Diluted EPS | -16.83 | -5.50 | -4.85 | -14.96 | -10.56 |
Average Basic Shares Outstanding | 7.98M | 7.96M | 7.89M | 7.85M | 7.87M |
Average Diluted Shares Outstanding | 7.98M | 7.96M | 7.89M | 7.85M | 7.87M |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |